Vaccines Market

Global Vaccines Market is valued at USD 56.98 Billion in 2021 and expected to reach USD 153.49 Billion by 2028 with a CAGR of 14.1% over the forecast period

Vaccines Market: Rising burden of several infectious and non-infectious diseases, increasing government and nongovernment support for vaccine development, and increasing Research and Underdevelopment likely to augment the growth of the Global Vaccine Market.

Scope:-

A vaccine is a biological preparation that is administered to produce active acquired immunity for a particular disease and it is prepared from weakened or killed forms of the microorganism such as bacteria & viruses or from its toxins or proteins. Administration of vaccines is called as “Vaccination” which aids to increase the immune response against a specific pathogen. The human body has natural ability to learn about eliminating all sorts of germs or microbes that cause diseases. The vaccine uses that ability of the body to enable it to defend itself from those microorganisms which have attacked it earlier. Usually, vaccines are administered through injections, orally and sprayed into the nose.Vaccines can be divides into many types such as inactivated vaccines, attenuated vaccines, toxoid, and conjugate. Cholera, influenza, hepatitis A, polio, and rabies vaccines are inactivated vaccines.

The Global Vaccines Market is categorized on the basis of the various diseases that can either be prevented or treated by using vaccines. Various diseases that are treated using H1N1 vaccines include influenza, meningococcal, cervical cancer, pneumococcal, hepatitis, measles, mumps, rubella, etc.The demand for vaccinations has increased over the last few years, due to the rising incidence of viral and bacterial infectious diseases. Vaccinations are essentially administered to people of different age groups, which build up their immune system throughout lifespan and gives protection against different types of infectious diseases. Vaccine technology is procedure to observe a revolution. As a more understanding of the human immune system’s protective antibody and cell-based responses to foreign antigens will causes the development of advanced diagnostics and improvement of therapeutic applications. As further governments across the

World identify the welfare of mass vaccination, the trend of vaccines providing healthcare solutions on a large scale will continue. Certain increasing demand worldwide and currently-unmet needs, the Global Vaccination Market has substantial potential for technological novelty and revenue growth.Vaccines are a supreme tool for effective healthcare management due to their low cost and prolonged protection. The increasing popularity of pediatric, travel, addiction and pediatric combination vaccines the newly developed vaccines that are safer and more effective, better public awareness, technological advancements in molecular genetics area and the adoption of novel vaccine delivery mechanisms are chiefly driving the growth of the global vaccination market. Moreover, the production of new therapeutic and prophylactic vaccines for fighting HIV/AIDS, congenital abnormalities, malaria and cancer, as well as other deadly diseases is also boost the Global Vaccine Market growth.

Immunization presently prevents an estimated 2 to 3 million deaths per year. Moreover additional 1.5 million deaths could be avoided due to enhanced global vaccination coverage. Increasing acceptance of new and underused vaccines will highly strengthen its global usage in the upcoming future.

Global Vaccines Market has been segmented on the basis of Technology, Indication, End User and Geography. On the basis of Technology, Global Vaccines Market is classified into Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines and Others. On the basis of Indication, Global Vaccines Market is segmented into Influenza, Pneumococcal Disease, Meningococcal Disease, Human Papilloma Virus, Rotavirus, Varicella, Diphtheria-Pertussis-Tetanus (DTP), Polio, Hepatitis, Measles-Mumps- Rubella (MMR) and others. On the basis of End User Global Vaccines Market is classified into Pediatric Vaccines, Adult Vaccines, Traveler Vaccines and Others.

The regions covered in Global Vaccines Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players:-

Global Vaccines Market reports cover prominent players like

• Glaxo Smith Kline plc
• Pfizer Inc.
• Merck & Co. Inc.
• Sanofi
• CSL Limited
• Emergent BioSolutions Inc.
• Johnson & Johnson
• Medimmune LLC
• AstellasPharma Inc.
• Serum Institute of India
• Bavarian Nordic
• Mitsubishi Tanabe Pharma Corporation
• Daiichi Sankyo Company Limited
• Panacea Biotech
• Protein Sciences Corporation
• AstraZeneca
• Abbott
• Bristol-Myers Squibb
• Novavax Inc.
• Gritstone Oncology
• PaxVax Corporation.
• Bharat Biotech.
• VBI Vaccines Inc.
• Dynavax Technologies Corporation
• Immunomic Therapeutics Inc.
• Gamma Vaccines Pty Limited
• Sinovac Biotech Ltd.
• Janssen Pharmaceutical Company
• Takeda Pharmaceuticals Company Ltd.
• Valeant Pharmaceuticals International Inc.
• China National Biotech
• Tiantan
• Hualan
• Kangtai
• Prokarium
• ImmunoBiology Ltd.

Segmentation:-

By Category

• Human

  • COVID 19 Vaccines
  • Pediatric Vaccines
  • Cancer Vaccines
  • Yellow fever Vaccine
  • Smallpox Vaccine
  • Hepatitis A vaccine
  • BCG Vaccine
  • olio vaccine
  • Flu Vaccine
  • Pneumococcal vaccine
  • Hepatitis B vaccine
  • Meningococcal Vaccines
  • Measles, Mumps and Rubella (MMR) Vaccines
  • Diphtheria Tetanus and Pertussis Vaccine
  • Zika Virus Vaccine
  • Ebola virus Vaccine
  • Varicella Vaccine
  • Shingles Vaccine
  • Cholera Vaccine
  • Typhoid Fever Vaccines
  • Swine Flu Vaccine
  • Anthrax Vaccine
  • Malaria Vaccine
  • Tick-borne encephalitis vaccine
  • Dengue Vaccine
  • Human Papillomavirus Vaccine
  • Others

• Animal

  • Bovine Vaccine
  • Companion animal vaccine
  • Aquaculture vaccines
  • Porcine Vaccine
  • Veterinary Clostridium Vaccine
  • Equine Influenza Vaccine
  • Canine Influenza vaccine
  • Multivalent Vaccines
  • Conjugate Vaccines
  • Therapeutic vaccines
  • Viral Vector vaccines
  • Inactivated Vaccines
  • DNA Vaccines
  • Bacterial Vaccines
  • Others

• Bird

  • Newcastle Disease Vaccine
  • Infectious Bronchitis Vaccine
  • Infectious Bursal Diseases Vaccine
  • Infectious Laryngotracheitis Vaccine
  • Egg Drop Syndrome Vaccine
  • Adenovirus Vaccine
  • Duck Viral Enteritis Vaccine
  • Inclusion Body Hepatitis Vaccine
  • Coccidiosis Vaccine
  • Avian Influenza Vaccine
  • Marek's Disease Vaccine
  • Salmonella Vaccine
  • Avian Encephalomyelitis Vaccine
  • Fowl Cholera Vaccine
  • Others   

By Vaccine Type

• Recombinant Vaccines
• Toxoid Vaccines
• Live Vaccines
• mRNA Vaccines
• Monovalent Vaccines
• Others

By End User

• Pediatric
• Adults
• Animal and Birds

Market Dynamics:–

The rise in acceptance of pediatrics, travel, addiction, and pediatric combination vaccines also recently developed vaccines that are safer and more effective, better, public awareness, technological advancements in molecular genetics area and the acceptance of new vaccine delivery mechanisms are mainly driving the growth of the Global Vaccination Market. Rise in incidence of infectious diseases such as influenza, malaria, pneumonia, measles, meningococcal meningitis, dengue, HIV, hepatitis, and diphtheria is somewhat high, as well as government initiatives for expanding vaccination coverage are likely to boost the demand for vaccines globally. The Government of Asian country launched the ‘Pan-India campaign for contagious disease-Rubella Vaccination’ in February 2017 to safeguard kids from chief childhood diseases like three-day measles and Measles.

This nationwide vaccination campaign aims to administer the measles-rubella vaccine (MR-VAC) to children aged between nine months and 15 years and increasing investments by companies are driving the vaccine market. Excessive cost related to storage and transportation of vaccines will restrain the Global Vaccine Market growth. Limited reimbursement coverage and stringent government regulations for the approval of products will further hamper the Global Vaccine Market expansion over the coming years. Crucial problems in the Global Vaccine Market nowadays are product safety, supply shortages, use of vaccines to prevent infectious diseases and discoveries in vaccine delivery systems

On Special Requirement Vaccines Market Report is also available for below Regions and Country:-

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Report Analysis	Details
Historical data	2018 - 2021
Forecast Period	2022 - 2028
Market Size in 2021:	USD 56.98 Billion
Base year considered	2021
Forecast Period CAGR %:	14.1%
Market Size Expected in 2028:	USD 153.49 Billion
Tables, Charts & Figures:	175
Pages	200
Companies	Glaxo Smith Kline plc, Pfizer Inc., Merck & Co. Inc., Sanofi, CSL Limited, Emergent BioSolutions Inc., Johnson & Johnson, Medimmune, LLC, AstellasPharma Inc., Serum Institute of India, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company Limited, Panacea Biotech, Protein Sciences Corporation, AstraZeneca, Abbott, Bristol-Myers Squibb, Novavax Inc., Gritstone Oncology, PaxVax Corporation.,Bharat Biotech., VBI Vaccines Inc., Dynavax Technologies Corporation, Immunomic Therapeutics, Inc., Gamma Vaccines Pty Limited, Sinovac Biotech Ltd., Janssen Pharmaceutical Company, Takeda Pharmaceuticals Company Ltd., Valeant Pharmaceuticals International, Inc., China National Biotech, Tiantan, Hualan, Kangtai, Prokarium, ImmunoBiology Ltd.
Segments Covered	By Technology, By Indication, By End-User
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Vaccines Market Outlook

MRNA Vaccine & Therapeutics Raw Material Market Key Takeaway

• Global MRNA Vaccine & Therapeutics Raw Material Market is valued at USD 11,635.3 Million in 2021
• It is expected to reach USD 1041.8 Million by 2024 
• Growing at a CAGR of -55.26% over the forecast period. 

Zika Virus Vaccine Market Key Takeaway

• Global Zika Virus Vaccine Market is valued at USD 18.11 Billion in 2021 
• It is expected to reach USD 25.22 Billion by 2028  
• Growing at a CAGR of 4.84% over the forecast period.

Smallpox Vaccine Market Key Takeaway

• Global Smallpox Vaccine Market is valued at USD 63.46 Million in 2020 
• It is expected to reach USD 78.58 Million by 2027
• Growing at a CAGR of 3.1% over the forecast period.